Publications by authors named "Sally Loi"

Claim this Profile
D
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitors.
Jean B Regard, Tyler J Harrison, Jake Axford, Laura Axford, Lac Lee, Sally Loi

Biochem Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia.
Anna Zuk, Zhihai Si, Sally Loi, Santhosh Bommegowda, Debie Hoivik

J Pharmacol Exp Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
Anup Patnaik, Laura Axford, Lin Deng, Evan Cohick, Xianglin Ren, Sally Loi

Bioorg Med Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor.
Martin L Marro, Andrew W Patterson, Lac Lee, Lin Deng, Aimee Reynolds, Sally Loi

J Pharmacol Exp Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis